Jun. 2 at 9:26 PM
The XBI is off 6.55% the last 2 days, the 17th biggest 2 day loss in the XBI since 12/31/21 (list attached). Recall in May 2022 the XBI lost 20.1% over 6 days.
Attached are all commercial-stage (oncology & non-oncology) bios who lost more than 10% in share price over the last 2 days...and the 2 winners. Oncology MCs over
$500MM & non-oncology over
$750MM
$LEGN has clearly been the best performing commercial-stage bio over the last 2 days after reporting stunning data in solid tumors this morning (not MM).
$ETON is a surprise considering 2 summers ago ETON traded for less than
$5.00 a share. There may still be an incredible story here as ETON only trades for 2.0X FY29 (Year 4) consensus with as diversified a product portfolio as they come.
$LXRX traded for
$1.25 a share just 4 months ago.
$PGEN traded for
$1.85 last summer before its first FDA approval
$LQDA still trades at 3.0X FY29 (Year 4) consensus but otherwise has been one of the strongest in the peer group (
$12.00 last summer
